[Severe peranesthetic anaphylactic accidents].
Laxenaire
M C
MC
Moneret-Vautrin
D A
DA
Vervloët
D
D
Alazia
M
M
François
G
G
D000707:Anaphylaxis / Q000139:chemically induced* / Q000175:diagnosis / Q000276:immunology / Q000517:prevention & control / Q000628:therapy; D000768:Anesthesia, General / Q000009:adverse effects*; D000777:Anesthetics / Q000009:adverse effects; D001007:Anxiety / Q000503:physiopathology; D001986:Bronchial Spasm / Q000139:chemically induced; D002318:Cardiovascular Diseases / Q000139:chemically induced; D003167:Complement Activation / Q000187:drug effects; D003875:Drug Eruptions / Q000209:etiology; D006636:Histamine Release / Q000187:drug effects; D006801:Humans; D006967:Hypersensitivity / Q000503:physiopathology; D007073:Immunoglobulin E / Q000032:analysis; D007074:Immunoglobulin G / Q000032:analysis; D009466:Neuromuscular Blocking Agents / Q000009:adverse effects; D009467:Neuromuscular Depolarizing Agents / Q000009:adverse effects; D012306:Risk; D012882:Skin Tests; D013746:Tetany / Q000503:physiopathology
D000777:Anesthetics; D007074:Immunoglobulin G; D009466:Neuromuscular Blocking Agents; D009467:Neuromuscular Depolarizing Agents; D007073:Immunoglobulin E
Accidents anaphylactoïdes graves peranesthésiques.